OXC401

fosbretabulin tromethamine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OXC401, covering 2017-02-09 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas [Phase 1]